help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on February 25, 2003, doi:10.1164/rccm.200209-1002OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200209-1002OCv1
167/10/1393    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hardy, C. L.
Right arrow Articles by O'Hehir, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardy, C. L.
Right arrow Articles by O'Hehir, R. E.
American Journal of Respiratory and Critical Care Medicine Vol 167. pp. 1393-1399, (2003)
© 2003 American Thoracic Society

Characterization of a Mouse Model of Allergy to a Major Occupational Latex Glove Allergen Hev b 5

Charles L. Hardy, Linda Kenins, Alexander C. Drew, Jennifer M. Rolland and Robyn E. O'Hehir

Cooperative Research Centre for Asthma; Department of Allergy, Asthma and Clinical Immunology, The Alfred Hospital;
and Department of Pathology and Immunology, Monash University, Melbourne, Australia

Correspondence and requests for reprints should be addressed to Charles Hardy, Cooperative Research Centre for Asthma, Department of Pathology and Immunology, Monash Medical School, Commercial Road, Melbourne, VIC 3004, Australia. E-mail: charles.hardy{at}med.monash.edu.au

Allergen-specific immunotherapy is a clinically proven effective treatment for many allergic diseases, including asthma; however, it is not currently available for latex allergy because of the high risk of anaphylaxis. There is, therefore, a crucial need for an animal model of latex allergy in which to develop effective immunotherapy. Previous mouse models of latex allergy either did not characterize the allergic pulmonary immune response or used crude latex extracts, making it difficult to quantify the contribution of individual proteins and limiting their usefulness for developing specific immunotherapy. We immunized mice with recombinant Hev b 5, a defined major latex allergen, or latex glove protein extract, representing the range of occupationally encountered processed latex allergens. The immune response was compared with that seen in ovalbumin-immunized mice. Immunization with Hev b 5 or glove extract elicits hallmarks of allergic pulmonary Th2-type immune responses, comparable to those for ovalbumin, including (1) serum antigen-specific IgE, (2) an eosinophilic inflammatory infiltrate in the lung, (3) increased interleukin-5 in lung bronchoalveolar lavage fluid, and (4) mucus hypersecretion by epithelial cells in the lung airways. This mouse model will aid the development of potentially curative treatments for latex-sensitized individuals, including those with occupational asthma.

Key Words: eosinophil • inflammation • interleukins • cytokines




This article has been cited by other articles:


Home page
ChestHome page
M. Fernandez-Nieto, B. Sastre, J. Sastre, C. Lahoz, S. Quirce, M. Madero, and V. del Pozo
Changes in Sputum Eicosanoids and Inflammatory Markers After Inhalation Challenges With Occupational Agents
Chest, November 1, 2009; 136(5): 1308 - 1315.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. M. Sansom, P. Riedmaier, H. J. Newton, M. A. Dunstone, C. E. Muller, H. Stephan, E. Byres, T. Beddoe, J. Rossjohn, P. J. Cowan, et al.
Enzymatic Properties of an Ecto-nucleoside Triphosphate Diphosphohydrolase from Legionella pneumophila: SUBSTRATE SPECIFICITY AND REQUIREMENT FOR VIRULENCE
J. Biol. Chem., May 9, 2008; 283(19): 12909 - 12918.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. Tobin
Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2003
Am. J. Respir. Crit. Care Med., January 15, 2004; 169(2): 265 - 276.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2003 American Thoracic Society
  Registrer for the conference